Sunday, December 4, 2022

Tag: Phase 1 and 2 trials


AstraZeneca’s Covid-19 vaccine shows robust responses in Phase I and II...

Interim results from the ongoing Phase I and II COV001 trial, led by Oxford University, showed that AstraZeneca's AZD1222 was tolerated and generated robust...

This function has been disabled for HealthTekPak.

error: Content is protected !!